National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 412933

Case Details

VAERS ID: 412933 (history)  
Form: Version 1.0  
Gender: Female  
Location: Unknown  
Submitted: 2010-12-15
Entered: 2010-12-16
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Abnormal behaviour, Brain injury, Convulsion, Cytogenetic analysis, Gait disturbance, Laboratory test, Memory impairment, Metabolic function test, Mood altered, Movement disorder, Respiratory arrest, Tic
SMQs:, Anaphylactic reaction (broad), Peripheral neuropathy (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (broad), Convulsions (narrow), Akathisia (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Acute central respiratory depression (narrow), Psychosis and psychotic disorders (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Hostility/aggression (broad), Conditions associated with central nervous system haemorrhages and cerebrovascular accidents (broad), Depression (excl suicide and self injury) (broad), Generalised convulsive seizures following immunisation (narrow), Hypersensitivity (broad), Respiratory failure (narrow), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Unknown
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC Split Type: WAES1012USA01990

Write-up: Information has been received from a consumer who had received the information from the internet. The information in the internet was received by a consumer concerning her healthy daughter who was vaccinated with the first and second dose of GARDASIL shortly after the patient experienced seizures. The firstly seizure caused the patient to loss breath and she was hospitalized for 4 months. The patient experienced brain damage, memory deficiency, behavioral problems, extreme mood changes, walking disorder, tics and seizures. The patient had lost one year of school and would be able to return to school only when the medication would better control her seizures. The patient underwent 4 months of tests to detect metabolic disorders, genetic disorders and several rare conditions with no results yet. By the time of this report the outcome is unknown. The reporter felt that seizures, brain damage, memory deficiency, behavioral problems, extreme mood change, walking disorder and tics were related to therapy with GARDASIL. No further information is available.

New Search

Link To This Search Result:

Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166